Why the study?
Are quantitative muscle MRI and ultrasound complementary imaging biomarkers for facioscapulohumeral muscular dystrophy?
Are quantitative muscle MRI and ultrasound complementary imaging biomarkers for facioscapulohumeral muscular dystrophy?
Quantitative muscle MRI and ultrasound offer complementary strengths as imaging biomarkers for facioscapulohumeral muscular dystrophy.
Supports complementary ultrasound-MRI use as FSHD biomarkers; leaves open prospective validation before clinical adoption.
Quantitative muscle MRI and ultrasound are both promising imaging biomarkers for differentiating between degrees of structural muscle changes. As ultrasound is more sensitive to detect subtle structural changes and MRI is more accurate in end stage muscles and detecting edema, the techniques are complementary. Hence, the choice for a particular technique should be considered in light of the trial design.
No takes yet. Share an insight, caveat, or question.
Mul et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: